Modifications du mode de vie dans la prise en charge du risque cardio-vasculaire

Cardiovascular Health Health Guideline 2017
France French PDF
National

AI-Generated Document Summary

Objectives

Reduce cardiovascular risk by making individualised lifestyle change the first-line intervention for all people, irrespective of baseline risk, while using medicines alongside lifestyle measures when clinically indicated.Promote healthier eating, regular physical activity, reduced sedentary behaviour and avoidance of tobacco exposure, with more intensive support for people at high or very high cardiovascular risk.

  • Provide therapeutic education and tailored dietary advice that account for each person’s eating habits and cardiovascular-risk profile.
  • Prioritise smoking cessation and protection from tobacco exposure as cardiovascular-risk-reduction measures.
  • Promote a Mediterranean-style diet, including fish two or three times weekly with oily fish at least once weekly, at least five portions or about 400 grams of fruit and vegetables daily, and lower salt consumption without requiring a salt-free diet.
  • Improve lipid profiles by reducing saturated and trans fats, favouring unsaturated fats, increasing dietary fibre, and limiting excessive calories, sugary foods and foods with a high glycaemic index where relevant.
  • Encourage oily fish, including sardines, mackerel and herring, as sources of long-chain omega-3 fatty acids, and consider eicosapentaenoic acid and docosahexaenoic acid supplementation where appropriate.
  • Moderate red-meat intake, keep dietary cholesterol below 300 milligrams daily, and strongly discourage alcohol consumption.
  • Increase physical activity progressively for the whole population where not medically contraindicated, regardless of age, past history or current activity level.
  • Encourage adults to complete at least 30 minutes of exercise on most days, totalling at least 150 minutes weekly of moderate-intensity activity, 75 minutes of vigorous aerobic activity, or an equivalent combination in bouts of at least 10 minutes.

Implementation

Deliver cardiovascular prevention through therapeutic education, negotiated patient-specific goals and continuing dietary support, combining diet and regular physical activity with drug treatment when indicated.Individualise the intensity and content of advice according to cardiovascular risk, lipid abnormality, age and clinical history, while avoiding unnecessarily restrictive diets that may cause nutritional imbalance or eating-related disorders.

  • Agree a small number of simple dietary and lifestyle objectives with each person, and maintain dietary support after therapeutic targets have been achieved.
  • Tailor dietary management for isolated hypercholesterolaemia by reducing saturated and trans fats and increasing fibre intake.
  • Address mixed dyslipidaemia by combining fat-quality and fibre measures with reduced excess calorie intake, particularly where abdominal weight, sugary foods or high-glycaemic-index foods contribute to risk.
  • Manage severe hypertriglyceridaemia by considering oily fish or omega-3 sources, assessing short-term alcohol abstinence, and subsequently testing the effects of different carbohydrate sources.
  • Avoid restrictive dietary advice for people aged over 80 because of undernutrition risk.
  • Advise people with a history of cardiovascular disease to obtain medical advice before undertaking vigorous activity.
  • Provide specific supervision for people with coronary disease, including measures such as exercise testing and cardiovascular rehabilitation.
  • Warn against using red-yeast-rice supplements containing monacolin K, or lovastatin, as alternatives to cholesterol-lowering medicines or in combination with statins, because they can cause statin-like adverse events and have low efficacy.
  • Engage patients, healthcare professionals delivering individualised advice and therapeutic education, and specialist input where medium-chain triglycerides may be considered; the supplied text does not specify named implementing institutions, governance arrangements, financing, or formal monitoring and accountability mechanisms.

Monitoring & Evaluation

The available extracts emphasise individualised lifestyle management and ongoing clinical support, but do not establish a formal monitoring, evaluation, reporting, surveillance or accountability framework.

  • Continue dietary support after a therapeutic target has been achieved, indicating an expectation of sustained follow-up rather than cessation of support at target attainment.
  • Assess dietary responses in severe hypertriglyceridaemia through short-term alcohol abstinence followed by evaluation of different carbohydrate sources.
  • Provide medical assessment before vigorous physical activity for people with a history of cardiovascular disease, and provide supervised measures such as exercise testing and cardiovascular rehabilitation for people with coronary disease.
  • Monitor individual clinical suitability for dietary and activity advice, including medical contraindications to physical activity and the risk of undernutrition from restrictive dietary advice among people aged over 80.
  • Recognise that no indicators, targets for service coverage or outcomes, data-collection procedures, reporting responsibilities, surveillance systems, evaluation methods or formal accountability arrangements are specified in the supplied text.

Costing & Financing

The available extracts do not specify programme costs, budgets, funding sources, allocations, resource-mobilisation mechanisms, funding gaps or economic assumptions for dietary counselling, therapeutic education, physical-activity promotion, clinical assessment or rehabilitation.

  • Provide therapeutic education, individualised dietary advice, continued dietary support and regular physical-activity promotion as components of lifestyle management, but without identifying the workforce, infrastructure or financial resources required.
  • Use specialist advice where medium-chain triglycerides may be considered for severe hypertriglyceridaemia, but without specifying the cost, funding route or eligibility budget for this support.
  • Provide exercise testing and cardiovascular rehabilitation for people with coronary disease where appropriate, but without stating the service budget, reimbursement mechanism, provider capacity or financing source.
  • Recognise that no explicit machine-readable monetary amounts, currency denominations, financing periods, funding commitments or quantified resource gaps are available in the supplied text.

Document Viewer